Literature DB >> 10532447

Clinical features of codon 172 RDS macular dystrophy: similar phenotype in 12 families.

S M Downes1, F W Fitzke, G E Holder, A M Payne, D A Bessant, S S Bhattacharya, A C Bird.   

Abstract

OBJECTIVE: To report the phenotype associated with the codon 172 RDS (gene for retinal degeneration slow) mutation in 11 separate families with an arginine-to-tryptophan substitution with common ancestry, and 1 family with an arginine-to-glutamine transition. PATIENTS: Screening for RDS gene mutations was performed in 400 subjects with autosomal dominant retinal degeneration. Twelve families were identified with a mutation in codon 172. Haplotype analysis was performed. Full ophthalmic evaluation was performed, including electrophysiologic and psychophysical investigation and imaging of autofluorescence using confocal laser scanning ophthalmoscopy.
RESULTS: Haplotype analysis demonstrated that the 11 families were ancestrally related. All 12 families showed a common phenotype of macular dysfunction, with the deficit increasing with age. Abnormally high autofluorescence predated loss of visual acuity or visual field changes. Pattern electroretinographic (PERG) findings were affected early in disease. There was high intrafamilial and interfamilial consistency of phenotype.
CONCLUSION: These families demonstrate a striking conformity of symptoms and signs. CLINICAL RELEVANCE: In the codon 172 RDS mutation, unlike disease resulting from other RDS mutations, prediction of approximate age of onset and progression of visual deficit is possible. This should assist diagnosis and counseling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10532447     DOI: 10.1001/archopht.117.10.1373

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  21 in total

1.  Genotype-phenotype correlation in British families with X linked congenital stationary night blindness.

Authors:  L E Allen; I Zito; K Bradshaw; R J Patel; A C Bird; F Fitzke; J R Yates; D Trump; A J Hardcastle; A T Moore
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

Review 2.  Genetic factors of age-related macular degeneration.

Authors:  Jingsheng Tuo; Christine M Bojanowski; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2004-03       Impact factor: 21.198

3.  Cone structure in retinal degeneration associated with mutations in the peripherin/RDS gene.

Authors:  Jacque L Duncan; Katherine E Talcott; Kavitha Ratnam; Sanna M Sundquist; Anya S Lucero; Shelley Day; Yuhua Zhang; Austin Roorda
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

4.  A novel mutation in the RDS gene in an Italian family with pattern dystrophy.

Authors:  F Testa; V Marini; S Rossi; E Interlandi; A Nesti; M Rinaldi; M Varano; C Garré; F Simonelli
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

5.  Chapter 8 - Restoring Vision to the Blind: Evaluating Visual Function, Endpoints.

Authors: 
Journal:  Transl Vis Sci Technol       Date:  2014-12-30       Impact factor: 3.283

Review 6.  Genotype-phenotype correlations and differential diagnosis in autosomal dominant macular disease.

Authors:  A Iannaccone
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

7.  Insights into the mechanisms of macular degeneration associated with the R172W mutation in RDS.

Authors:  Shannon M Conley; Michael W Stuck; Justin L Burnett; Dibyendu Chakraborty; Seifollah Azadi; Steven J Fliesler; Muna I Naash
Journal:  Hum Mol Genet       Date:  2014-01-25       Impact factor: 6.150

Review 8.  The genetics of inherited macular dystrophies.

Authors:  M Michaelides; D M Hunt; A T Moore
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

Review 9.  PRPH2/RDS and ROM-1: Historical context, current views and future considerations.

Authors:  Michael W Stuck; Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2016-01-08       Impact factor: 21.198

Review 10.  Gene therapy for PRPH2-associated ocular disease: challenges and prospects.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-28       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.